Rapid Development of Piperidine
Carboxamides as Potent
and Selective Anaplastic Lymphoma Kinase Inhibitors
- Publication date
- Publisher
Abstract
Piperidine carboxamide <b>1</b> was identified
as a novel
inhibitor of anaplastic lymphoma kinase (ALK enzyme assay IC<sub>50</sub> = 0.174 μM) during high throughput screening, with selectivity
over the related kinase insulin-like growth factor-1 (IGF1R). The
X-ray cocrystal structure of <b>1</b> with the ALK kinase domain
revealed an unusual DFG-shifted conformation, allowing access to an
extended hydrophobic pocket. Structure–activity relationship
(SAR) studies were focused on the rapid parallel optimization of both
the right- and left-hand side of the molecule, culminating in molecules
with improved potency and selectivity over IGF1R